HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MicroRNAs targeting VEGF are related to vascular dysfunction in preeclampsia.

Abstract
In preeclampsia (PE), pre-existent maternal endothelial dysfunction leads to impaired placentation and vascular maladaptation. The vascular endothelial growth factor (VEGF) pathway is essential in the placentation process and VEGF expression is regulated through post-transcriptional modification by microRNAs (miRNAs). We investigated the expression of VEGF-related circulating miR-16, miR-29b, miR-126, miR-155 and miR-200c in PE vs healthy pregnancies (HPs), and their relation with vascular function, oxidative stress (OS) and systemic inflammation. In this case-control study, 24 women with early PE (<34 weeks) were compared with 30 women with HP. Circulating microRNA levels (RT-qPCR), OS and systemic inflammation were assessed in plasma samples (PE 29.5 vs HP 25.8 weeks) and related to extensive in vivo vascular function (flow-mediated dilatation (FMD), modified FMD (mFMD), carotid-femoral pulse wave velocity (CF-PWV), heart rate corrected augmentation index (AIx75) and reactive hyperemia index (RHI)). FMD, CF-PWV, AIx75 and RHI were all significantly impaired in PE (P<0.05). PE patients had reduced levels of miR-16 (5.53 ± 0.36 vs 5.84 ± 0.61) and increased levels of miR-200c (1.34 ± 0.57 vs 0.97 ± 0.68) (P<0.05). Independent of age and parity, miR-16 was related to impaired FMD (β 2.771, 95% C.I.: 0.023-5.519, P=0.048) and mFMD (β 3.401, 95% C.I.: 0.201-6.602, P=0.038). Likewise, miR-200c was independently associated with CF-PWV (β 0.513, 95% C.I.: 0.034-0.992, P=0.036). In conclusion, circulating levels of miR-16 were lower in PE, which correlated with impaired endothelial function. Circulating miR-200c was increased in PE and correlated with higher arterial stiffness. These findings suggest a post-transcriptional dysregulation of the VEGF pathway in PE and identify miR-16 and miR-200c as possible diagnostic biomarkers for PE.
AuthorsIsabel Witvrouwen, Dominique Mannaerts, Jessica Ratajczak, Evi Boeren, Ellen Faes, Amaryllis H Van Craenenbroeck, Yves Jacquemyn, Emeline M Van Craenenbroeck
JournalBioscience reports (Biosci Rep) Vol. 41 Issue 8 (08 27 2021) ISSN: 1573-4935 [Electronic] England
PMID34318873 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2021 The Author(s).
Chemical References
  • Circulating MicroRNA
  • MIRN16 microRNA, human
  • MIRN200 microRNA, human
  • MicroRNAs
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
Topics
  • Adult
  • Case-Control Studies
  • Circulating MicroRNA (blood, genetics)
  • Female
  • Gene Expression Regulation
  • Heart Rate
  • Humans
  • Hyperemia (genetics, metabolism, physiopathology)
  • Inflammation (blood, genetics)
  • MicroRNAs (blood, genetics)
  • Oxidative Stress
  • Pre-Eclampsia (blood, diagnosis, genetics, physiopathology)
  • Pregnancy
  • Prospective Studies
  • Pulse Wave Analysis
  • Vascular Endothelial Growth Factor A (genetics, metabolism)
  • Vascular Stiffness
  • Vasodilation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: